Walmart Health Center Exit: Is It Good For Clinical Trials?
This article contains speculative content, opinions, and assumptions about the Walmart Health center that are not confirmed facts. The...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Patient Stratification Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
This article contains speculative content, opinions, and assumptions about the Walmart Health center that are not confirmed facts. The...
C2N Diagnostics has partnered with Mediford Corporation, a subsidiary of PHC Holdings, to enhance access to its clinical research...
The U.S. Food and Drug Administration (FDA) has approved an updated label for Biktarvy, extending its safety and efficacy...
Pfizer’s BEQVEZ, a one-time gene therapy, has received FDA approval for treating adults with moderate to severe hemophilia B....
The U.S. Food and Drug Administration (FDA) has granted full approval to TIVDAK (tisotumab vedotin-tftv) for the treatment of...
A Phase 3 trial (STRIDE-10) evaluated V116, a 21-valent pneumococcal conjugate vaccine, in adults over 50. The study compared...
In this interview, Jeffrey Sorenson, CEO of Yunu, outlines how his company is enhancing the precision and efficiency of...
Rising levels of obesity have become a global health issue, with an estimated 2.8 million people dying each year...
In the evolving field of clinical trials, Risk-Based Quality Management (RBQM) emerges as a cornerstone for enhancing trial efficiency...
Vividion Therapeutics, a biopharmaceutical company, has made a significant discovery in the development of novel cancer and immune disorder...